Table 3.
Patients’ clinical features.
| Age groups | |
|---|---|
| Children (0–14 years) | 2 (2.7%) |
| Teenagers and young adults (15–24 years) | 1 (1.35%) |
| Adults (25–49 years) | 28 (37.83%) |
| Old age (50–74 years) | 43 (58.1%) |
| Menopause | |
| Premenopausal no. (%) | 34 (46%) |
| Postmenopausal no. (%) | 40 (54%) |
| Family history | |
| Positive no. (%) | 0 |
| Negative no. (%) | 74 (100%) |
| FIGO stages | |
| Stage I no. (%) | 58 (78.3%) |
| Stage III no. (%) | 16 (21.6%) |
| Histological type of tumor | |
| Serous | 32 (43.24%) |
| Mucinous | 18 (24.32%) |
| Endometrioid | 15 (20.27%) |
| Germ cell tumor | 4 (5.4%) |
| Clear cell | 4 (5.4%) |
| Burner tumor | 1 (1.35%) |